Moat Ross

US insider· US
Sign in for alerts
  • ACQUIREDStale

    Kiniksa Pharmaceuticals Intl · NASDAQ

    +2,457 sh

    Filed 3 Sept 2026SEC Form 4view source
  • ACQUIREDStale

    Kiniksa Pharmaceuticals Intl · NASDAQ

    +2,477 sh

    Filed 3 Sept 2026SEC Form 4view source
  • REDUCEDStale

    Kiniksa Pharmaceuticals Intl · NASDAQ

    −4,007 sh · $317.7K

    Filed 3 Sept 2026SEC Form 4view source
  • ACQUIREDStale

    Kiniksa Pharmaceuticals Intl · NASDAQ

    +1,740 sh

    Filed 3 Sept 2026SEC Form 4view source
  • ACQUIREDStale

    Kiniksa Pharmaceuticals Intl · NASDAQ

    +1,611 sh

    Filed 3 Sept 2026SEC Form 4view source